| value |
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1822479/0001104659-26-040937.txt","as_of":"2026-04-09T03:12:49.786272+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1822479/0001104659-26-040937.txt","company":"Sotera Health Co","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1822479/0001104659-26-040937.txt","article_chars":5000,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_00204bb0cb3a45e2","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1822479/0001104659-26-040937.txt","content_type":"text/plain","enriched_at":"2026-04-09T18:03:10.977704+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"tm261581-1_nonfiling - none - 20.3989098s","final_url":"https://www.sec.gov/Archives/edgar/data/1822479/0001104659-26-040937.txt","html_truncated":true,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1822479/0001104659-26-040937.txt","source_event_id":"evt_e0c16c80d741","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"DEF 14A","fp":"6273725a9393c113","kind":"sec_filing","published_at":"20260408","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.86,"dates_mentioned":["2026-04-08","2026-05-21","2026-03-27","2026-05-20","2026-12-31","2026-04-09T03:12:49.786272+00:00"],"entities":[{"asset_class":"equity","name":"Sotera Health Company","relevance":"high","symbol":"","type":"issuer"},{"asset_class":"professional_services","name":"Ernst & Young LLP","relevance":"medium","symbol":"","type":"auditor"},{"asset_class":"equity","name":"Sean L. Cunningham","relevance":"medium","symbol":"","type":"director_nominee"},{"asset_class":"equity","name":"Richard G. Kyle","relevance":"medium","symbol":"","type":"director_nominee"},{"asset_class":"equity","name":"Vincent K. Petrella","relevance":"medium","symbol":"","type":"director_nominee"},{"asset_class":"equity","name":"Christopher A. Simon","relevance":"medium","symbol":"","type":"director_nominee"}],"event_type":"listing","information_gaps":["What changed vs prior known state is not provided in the signal text (no prior filing comparison details included).","The filing\u2019s full contents beyond the notice/proposals section are not included in the provided excerpt (e.g., executive compensation specifics, governance details, risk factors).","The proxy statement\u2019s signature block (e.g., the rest of the \u201cBy order of the Board of Directors, Erika \u2026\u201d) is truncated, so the signatory name/title is not fully captured."],"key_facts":["SEC filing type: DEF 14A (definitive proxy statement).","Issuer: Sotera Health Company (Central Index Key: 0001822479).","Filed as of date: 2026-04-08; conforming period of report: 2026-05-21.","Annual meeting: Thursday, May 21, 2026 at 9:00 a.m. Eastern Daylight Time; held virtually via www.virtualshareholdermeeting.com/SHC2026.","Record date: Friday, March 27, 2026 (stockholders of record at close of business entitled to vote).","Proposals include electing four Class III directors: Sean L. Cunningham, Richard G. Kyle, Vincent K. Petrella, and Christopher A. Simon, each serving a three-year term ending in 2029.","Proposal includes an advisory approval of the compensation of named executive officers.","Proposal includes ratification of Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026.","Voting deadline stated: votes received by 11:59 p.m. Eastern Daylight Time on Wednesday, May 20, 2026 (for internet/telephone voting)."],"numeric_claims":[{"label":"Annual meeting date","value":"2026-05-21"},{"label":"Annual meeting time (ET)","value":"9:00 a.m."},{"label":"Record date","value":"2026-03-27"},{"label":"Voting deadline (ET)","value":"11:59 p.m. on 2026-05-20"},{"label":"Director term end year","value":"2029"},{"label":"Fiscal year end for auditor ratification","value":"2026-12-31"}],"primary_claim":"Sotera Health Company filed Form DEF 14A on 2026-04-08 for its 2026 annual meeting of stockholders scheduled for May 21, 2026 (virtual).","relevance_score":0.55,"sentiment":"neutral","source_quality":"high","summary":"Sotera Health Company filed a definitive proxy statement (DEF 14A) with the SEC on 2026-04-08. The filing announces its 2026 annual meeting (virtual) and lists director nominees, an advisory vote on executive compensation, and ratification of its independent auditor.","topics":["SEC filing","proxy statement","annual meeting","board of directors","executive compensation (advisory)","independent auditor ratification","virtual meeting logistics"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form DEF 14A \u00b7 Sotera Health Co \u00b7 Filed 20260408","ticker":"SHC","tickers":["SHC"],"title":"SHC filed DEF 14A","url":"https://www.sec.gov/Archives/edgar/data/1822479/0001104659-26-040937.txt"}... |